Radiopharm Theranostics (RADX) Accounts Payables (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Accounts Payables for 2 consecutive years, with $9.3 million as the latest value for Q2 2025.

• Quarterly Accounts Payables fell 13.96% to $9.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Jun 2025, down 13.96% year-over-year, with the annual reading at $9.3 million for FY2025, 13.96% down from the prior year.
• Accounts Payables for Q2 2025 was $9.3 million at Radiopharm Theranostics, down from $10.9 million in the prior quarter.
• The five-year high for Accounts Payables was $10.9 million in Q2 2024, with the low at $9.3 million in Q2 2025.

Peer Comparison